609 related articles for article (PubMed ID: 17582508)
21. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
22. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
23. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
Nierenberg AA; Friedman ES; Bowden CL; Sylvia LG; Thase ME; Ketter T; Ostacher MJ; Leon AC; Reilly-Harrington N; Iosifescu DV; Pencina M; Severe JB; Calabrese JR
Am J Psychiatry; 2013 Jan; 170(1):102-10. PubMed ID: 23288387
[TBL] [Abstract][Full Text] [Related]
24. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
[TBL] [Abstract][Full Text] [Related]
25. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
[TBL] [Abstract][Full Text] [Related]
26. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
[TBL] [Abstract][Full Text] [Related]
27. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
Tohen M; Ketter TA; Zarate CA; Suppes T; Frye M; Altshuler L; Zajecka J; Schuh LM; Risser RC; Brown E; Baker RW
Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
[TBL] [Abstract][Full Text] [Related]
28. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
31. Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Arvilommi P; Suominen K; Mantere O; Leppämäki S; Valtonen HM; Isometsä E
J Affect Disord; 2010 Feb; 121(1-2):116-26. PubMed ID: 19497622
[TBL] [Abstract][Full Text] [Related]
32. Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.
Houston JP; Lipkovich IA; Ahl J; Rotelli MD; Baker RW; Bowden CL
J Psychiatr Res; 2007 Oct; 41(7):616-21. PubMed ID: 16236320
[TBL] [Abstract][Full Text] [Related]
33. Algorithms for bipolar mania.
Post RM; Denicoff KD; Frye MA; Leverich GS
Mod Probl Pharmacopsychiatry; 1997; 25():114-45. PubMed ID: 9344373
[No Abstract] [Full Text] [Related]
34. Adjunctive treatment of acute mania: a clinical overview.
Sachs GS; Gardner-Schuster EE
Acta Psychiatr Scand Suppl; 2007; (434):27-34. PubMed ID: 17688460
[TBL] [Abstract][Full Text] [Related]
35. Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania.
Chandrasena R; Dvoráková D; Lee SI; Loza N; Mosolov SN; Osváth P; Pregelj P; Walton RJ; Karagianis J; Treuer T
Int J Clin Pract; 2009 Aug; 63(8):1249-58. PubMed ID: 19558486
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study.
Chen J; Muzina DJ; Kemp DE; Conroy C; Chan P; Serrano MB; Ganocy SJ; Fang Y; Calabrese JR; Gao K
Hum Psychopharmacol; 2011 Dec; 26(8):588-95. PubMed ID: 22086757
[TBL] [Abstract][Full Text] [Related]
37. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.
Frazier JA; Biederman J; Tohen M; Feldman PD; Jacobs TG; Toma V; Rater MA; Tarazi RA; Kim GS; Garfield SB; Sohma M; Gonzalez-Heydrich J; Risser RC; Nowlin ZM
J Child Adolesc Psychopharmacol; 2001; 11(3):239-50. PubMed ID: 11642474
[TBL] [Abstract][Full Text] [Related]
38. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
[TBL] [Abstract][Full Text] [Related]
40. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
